ALK37-003: A Study of RDC-1036 (ALKS 37) in Adults With Opioid-induced Constipation (OIC)

Phase 2 Completed 60 enrolled Alkermes, Inc.

RandomizedSingle-groupQuadruple-blindTreatment

Summary

The purpose of this study is to assess the safety and tolerability of RDC-1036 (ALKS 37) in adults with opioid-induced constipation (OIC) following repeat dose administration

Timeline

Start: 2010-04
Primary completion: 2010-12
Completion: 2010-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	METHYLSAMIDORPHAN	Small molecule	—	Oral

ALK37-003: A Study of RDC-1036 (ALKS 37) in Adults With Opioid-induced Constipation (OIC)

Summary

Timeline

Drugs

Indications